Navigation

Investiment.io
Financial analysis platform

Merck & Co., Inc.

MRK โ€ข NYSE

$144.46
โ–ผ3.30 (2.23%)โ€ข REGULAR

Merck & Co., Inc.

$144.46
โ–ผ2.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading

๐Ÿ“ˆ Advanced DCF Valuation

Professional-grade discounted cash flow analysis with scenario modeling for MRK

Healthcare โ€ข Drug Manufacturers - General โ€ข Market Cap: $364,264,702,858.88

Scenario Analysis

Compare different scenarios to understand valuation sensitivity

๐Ÿ”ป-100.0% upside

Conservative Case

$0.00

๐Ÿ“Š-98.8% upside

Base Case

$1.74

๐Ÿ”บ-96.7% upside

Optimistic Case

$4.84

๐Ÿ’ฐMarket Price

Current Price

$147.76

DCF Model & Results

Detailed cash flow projections and valuation analysis

๐Ÿ’ต Enhanced Cash Flow Projections

YearRevenueGrowth %Operating Margin %NOPATCapExFCFPV of FCF
1$70,078,650,179.927.8%15.0%$8,304,320,046.32$4,605,292,537.07$5,776,048,763.75$5,288,509,750.08
2$74,995,059,337.977.0%11.3%$6,665,185,898.66$4,664,397,031.19$4,226,058,601.82$3,542,749,387.56
3$79,671,790,672.026.2%8.4%$5,310,622,796.98$4,689,781,837.35$2,987,611,023.13$2,293,144,531.01
4$84,019,118,586.275.5%6.3%$4,200,299,529.95$4,680,639,397.02$2,018,497,050.95$1,418,528,129.98
5$87,948,725,896.614.7%4.7%$3,297,561,896.56$4,636,917,444.41$1,279,458,192.49$823,262,608.90
Terminalโ€”3.0%โ€”โ€”โ€”$40,049,570,072.35$25,769,746,707.30
Enterprise Value$39,135,941,114.84
Net Debt$34,774,000,000.00
Equity Value$4,361,941,114.84
Price per Share$1.74
EV/Revenue (Final Year)0.4x
Terminal Value %65.8%
WACC9.2%

๐Ÿฅ Company Financial Health

Historical Revenue Growth7.8%
Current Operating Margin0.0%
FCF Conversion Rate19.0%
Net Debt/Equity0.00
ROE0.0%
ROIC0.0%
Beta1.20
Interest Coverage0.00
Enhanced DCF data sourced from Financial Modeling Prep (FMP) โ€ข Model incorporates industry best practices and academic research โ€ข Calculations are estimates and should not be used as sole investment advice โ€ข Consult with a financial advisor before making investment decisions